Information
-
Trademark
-
86554584
-
International Classifications
-
Filing Date
March 05, 2015
10 years ago
-
Transaction Date
June 12, 2015
10 years ago
-
Status Date
June 12, 2015
10 years ago
-
Location Date
June 12, 2015
10 years ago
-
Status Code
641
-
Current Location
TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED
Employee Name
BULLOFF, TOBY ELLEN
-
Attorney Docket Number
V0279.20000U
Attorney Name
Christina M. Licursi
Law Office Assigned Location Code
N10
-
Owners
Mark Drawing Code
4000
Mark Identification
GLYCOBIOME
Case File Statements
- GS0421: Genetic testing for scientific research purposes; Genetic testing for medical purposes; scientific and technological services, including acquisition, collection, analysis, compilation, electronic storage and distribution of metagenomic, metaproteomic, metatranscriptomic, and metabolomic data and related clinical, agricultural, and veterinary data for treatment and diagnostic purposes of humans, animals, and plants; development of computer databases and computer-readable programs, software, and scientific, analytical, and statistical tools for genomic, proteomic, transcriptomic, and metabolomic data, including patient clinical care information, veterinary care information, agricultural data, and medical research data; chemical, biochemical, and molecular diagnostic services, including chemical, immunological, and microbiological diagnostic service bacteriological, virological, fungal, protistal, and molecular diagnostic services; acquisition, collection, analysis, compilation, storage and distribution of biological samples, including microbial and tissue samples; diagnostic services for assessing health and determining treatment for metabolism, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; scientific research in the field of genetics, genetic engineering of microbes, and molecular testing; Research and development in the pharmaceutical and biotechnology fields; microbial and anti-microbial preparations and substances for pharmaceutical, veterinary and medical purposes for use in the treatment of metabolic disorders, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; dietary supplements, nutritional supplements, nutraceuticals, food supplements, beverages, nutritional food bars, and animal feed or feed supplements containing microorganisms for medical, veterinary, therapeutic or preventative purposes; therapeutic pharmaceuticals containing microorganisms for medical and veterinary use for the treatment or prevention of metabolic disorders, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; therapeutics, consumer products and articles, including moisturizers, creams, lotions, gels, toners, cleansers, bandages, and cosmetics, pharmaceutical, veterinary and medical preparations and substances diagnostic kits and diagnostic reagents; diagnostics and tools for medical purposes; instruments, supplies and disposables; computer databases and computer-readable programs, software, and scientific, analytical, and statistical tools
Case File Event Statements
-
6/12/2015 - 10 years ago
5 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/12/2015 - 10 years ago
4 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
6/12/2015 - 10 years ago
3 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/10/2015 - 10 years ago
2 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/18/2015 - 10 years ago
1 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS